Rialto Wealth Management, LLC Ventyx Biosciences, Inc. Transaction History
Rialto Wealth Management, LLC
- $342 Million
- Q2 2025
A detailed history of Rialto Wealth Management, LLC transactions in Ventyx Biosciences, Inc. stock. As of the latest transaction made, Rialto Wealth Management, LLC holds 296 shares of VTYX stock, worth $1,065. This represents 0.0% of its overall portfolio holdings.
Number of Shares
296Holding current value
$1,065% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VTYX
# of Institutions
122Shares Held
49.4MCall Options Held
70.4KPut Options Held
51.4K-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.9MShares$21.2 Million0.03% of portfolio
-
Black Rock Inc. New York, NY4.77MShares$17.2 Million0.0% of portfolio
-
Affinity Asset Advisors, LLC New York, NY4.54MShares$16.3 Million1.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.16MShares$11.4 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA3.1MShares$11.2 Million0.4% of portfolio
About Ventyx Biosciences, Inc.
- Ticker VTYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,527,200
- Market Cap $203M
- Description
- Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...